Results 31 to 40 of about 63,187 (253)

Plasma lipoprotein metabolism in lean and in fat chickens produced by divergent selection for plasma very low density lipoprotein concentration.

open access: yesJournal of Lipid Research, 1989
Plasma lipoprotein metabolism was studied in vivo in two lines of chickens produced by selection for high and low plasma very low density lipoprotein (VLDL) concentration.
H Griffin, F Acamovic, K Guo, J Peddie
doaj   +1 more source

Acquired VLDL receptor deficiency in experimental nephrosis

open access: yes, 1997
Acquired VLDL receptor deficiency in experimental nephrosis. Nephrotic syndrome (NS) is commonly associated with elevation of plasma very low density lipoprotein (VLDL) and triglyceride concentrations.
Liang, Kaihui, Vaziri, Nosratola D.
core   +1 more source

Oxidized type IV hypertriglyceridemic VLDL-remnants cause greater macrophage cholesteryl ester accumulation than oxidized LDL

open access: yesJournal of Lipid Research, 1998
We have previously shown that very low density lipoproteins (VLDL, Sf 60–400) from subjects with type IV hyperlipoproteinemia (HTG-VLDL) will induce appreciable cholesteryl ester accumulation in cultured macrophages (J774A.1).
Stewart C. Whitman   +4 more
doaj   +1 more source

Effects of Add‐On Icosapent Ethyl With Standard Treatment on Functional Outcomes and Inflammatory Biomarkers in Acute Ischemic Stroke: A Blinded Randomized Controlled Trial

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Ischemic stroke, a major cause of mortality and long‐term disability, results from the abrupt cessation of cerebral blood flow due to vascular occlusion or rupture. Icosapent Ethyl (EPA‐EE), approved for hypertriglyceridemia, has anti‐inflammatory and antithrombotic properties that may lessen ischemic damage.
Mitra Mahmoudi Meymand   +5 more
wiley   +1 more source

Systemic Review to Explore the Effect of Dyslipidaemia and Metabolic Function in Coronary Heart Disease with Type 2 Diabetes Mellitus: In Tertiary Care Center

open access: yesJournal of Pharmacy and Bioallied Sciences
Metabolic dyslipidemia (high triglyceride) and low high-density lipoprotein cholesterol (HDL-C) are highly prevalent in type 2 diabetes mellitus (T2DM).
Akansha Singh   +2 more
doaj   +1 more source

Lipolytic remnants of human VLDL produced in vitro: effect of HDL levels in the lipolysis mixtures on the apoCs to apoE ratio and metabolic properties of VLDL core remnants

open access: yesJournal of Lipid Research, 2000
To determine the role of high-density lipoprotein (HDL) as an acceptor of lipolytic surface remnants of very low density lipoprotein (VLDL) in the metabolism of VLDL core remnants, we examined the effect of HDL levels in the VLDL lipolysis mixture on 1 ...
Byung Hong Chung, Nassrin Dashti
doaj   +1 more source

Apolipoprotein VLDL-II mediates VLDL particle size in laying hens -synergism with microsomal triglyceride transfer protein functionality

open access: yes, 2021
鳥類胚胎營養來源完全依賴蛋黃中脂質供應,因此母鳥於產蛋期間需提供更多脂質以形成蛋黃。產蛋母鳥之VLDL與未產蛋母鳥有以下幾點不同:1) 較小之粒徑以通過顆粒細胞基底膜,2) 較高的三酸甘油酯與磷脂比率,3) VLDL上鑲嵌著鳥類所獨有,受到雌激素誘導生成的載脂蛋白Apolipoprotein VLDL-II,此蛋白質已被證實可干擾VLDL脂蛋白分解酶作用(Lipoprotein lipase, LPL),保護VLDL於血液循環中運輸,完整的進入濾泡蓄積成蛋黃。但apo VLDL ...
Yu-Lin Ye, 葉宥麟
core  

Dysregulated Cholesterol Metabolism, Chronic Inflammation, and Disability in Severe Progressive Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Dysregulated lipid metabolism, which can affect remyelination and neural repair, has not been extensively investigated in progressive multiple sclerosis (PMS). The goal was to examine whether dysregulated cholesterol metabolism was associated with disability in PMS. Methods The study sample comprised 53 Severe PMS patients (Expanded
Taylor R. Wicks   +8 more
wiley   +1 more source

Endogenous cholesterol synthesis is associated with VLDL-2 apoB-100 production in healthy humans

open access: yesJournal of Lipid Research, 2003
Subjects with high plasma cholesterol levels exhibit a high production of VLDL apolipoprotein B-100 (apoB-100), suggesting that cholesterol is a mediator for VLDL production.
Berthil H.C.M.T. Prinsen   +8 more
doaj   +1 more source

Apolipoprotein-AI Regulates Hepatic VLDL Secretion by Controlling Intracellular VLDL-Trafficking [PDF]

open access: yes, 2016
Cardiovascular diseases cause 17 million deaths annually, which is estimated to increase to 23 million deaths by the year 2030. One of the major risk factors for the pathogenesis of cardiovascular diseases is increased secretion of very-low density ...
Gurwani, Bhavesh
core  

Home - About - Disclaimer - Privacy